Skip to main content
Regentis Biomaterials Ltd. (RGNT)
Regentis Biomaterials will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$10.00 - $12.00
Shares Offered
909,090
Deal Size
$10.00M

Regentis Biomaterials Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
 TTM Dec '23 Dec '22
Net Income
6.36-4.13-1.45
Other Operating Activities
-6.822.91-0.06
Operating Cash Flow
-0.46-1.22-1.5
Debt Issued / Paid
-0.33-
Financing Cash Flow
0.150.33-
Net Cash Flow
-0.31-0.9-1.5
Free Cash Flow
-0.46-1.22-1.5
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).